Ftse Mib
33.294,96
0,20%
DAX
19.146,17
0,76%
S&P 500
5.948,71
0,53%
NASDAQ
18.972,42
0,03%
Bitcoin
98.513,61
0,00%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 10x Genomics Inc (TXG) 10x Genomics Inc (TXG) Notizie

10x Genomics Inc

TXG
13,04
-0,28 (-2,10%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:53:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/11/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05PRNUS10x Genomics to Present at the Wolfe Research 2024..
31/10/202413:00PRNUSTechBio Startup Cure51 Selects 10x Genomics Visium HD for..
29/10/202421:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:05PRNUS10x Genomics Reports Third Quarter 2024 Financial Results
29/10/202421:04EDGAR2Form 8-K - Current report
15/10/202422:05PRNUS10x Genomics Delivers 'Single Cell for a Single Cent' with..
10/10/202412:45IHMARKETNEWSTesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits;..
09/10/202422:07EDGAR2Form 8-K - Current report
09/10/202422:05PRNUS10x Genomics Announces Preliminary Select Third Quarter 2024..
01/10/202422:05PRNUS10x Genomics Announces Mega-Scale Single Cell Analysis for..
10/9/202415:00PRNUSLausanne Researchers Combine 10x Genomics' Chromium and..
04/9/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:05PRNUS10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to..
26/8/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202402:45EDGAR2Form 144 - Report of proposed sale of securities
23/8/202402:42EDGAR2Form 144 - Report of proposed sale of securities
23/8/202402:39EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:05PRNUS10x Genomics to Present at the Morgan Stanley 22nd Annual..
20/8/202422:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:08EDGAR2Form 8-K - Current report
08/8/202422:05PRNUS10x Genomics Announces Senior Leadership Changes
08/8/202422:04PRNUS10x Genomics Reports Second Quarter 2024 Financial Results
05/8/202422:00PRNUS10x Genomics Technology Supports TenK10K Project Led by..
19/7/202422:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/7/202414:00PRNUS10x Genomics to Report Second Quarter 2024 Financial Results..
11/7/202422:08EDGAR2Form 8-K - Current report
11/7/202412:17IHMARKETNEWSCostco Hikes Membership Fees; ON Semiconductor Stock Drops..
27/6/202415:00PRNUSNew Insights Into Cleft Palate Unlocked With 10x Genomics'..
20/6/202415:00PRNUS10x Genomics Begins Commercial Shipments of Xenium Prime 5K..
13/6/202422:08EDGAR2Form 8-K - Current report
06/6/202422:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:05PRNUS10x Genomics Launches 5,000-Plex Gene Panel for Xenium
24/5/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:27EDGAR2Form 144 - Report of proposed sale of securities
22/5/202422:23EDGAR2Form 144 - Report of proposed sale of securities
22/5/202422:17EDGAR2Form 144 - Report of proposed sale of securities
02/5/202422:05PRNUS10x Genomics to Present at the BofA Securities 2024..
30/4/202422:05PRNUS10x Genomics Reports First Quarter 2024 Financial Results
10/4/202422:05PRNUS10x Genomics to Report First Quarter 2024 Financial Results..
26/3/202414:00PRNUS10x Genomics Commercially Launches Visium HD Spatial Gene..
21/3/202421:05PRNUS10x Genomics Expands Xenium Menu with Multi-Modal Cell..
13/3/202421:05PRNUS10x Genomics Begins Commercial Shipments of Chromium GEM-X..
06/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 13,30 Min: 13,015 Max: 13,51
Chiusura: 13,32

La tua Cronologia

NASDAQ
TXG
10x Genomics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network